APA (7th ed.) Citation

BJ, R., AM, S., PM, H., DM, C., ATR, A., Rembacken, B. J., . . . Axon, A. T. (1999). Non-pathogenic Escherichia coli versus mesalazine for the treatment of ulcerative colitis: A randomised trial. Lancet, 354(9179), 635. https://doi.org/10.1016/s0140-6736(98)06343-0

Chicago Style (17th ed.) Citation

BJ, Rembacken, et al. "Non-pathogenic Escherichia Coli Versus Mesalazine for the Treatment of Ulcerative Colitis: A Randomised Trial." Lancet 354, no. 9179 (1999): 635. https://doi.org/10.1016/s0140-6736(98)06343-0.

MLA (9th ed.) Citation

BJ, Rembacken, et al. "Non-pathogenic Escherichia Coli Versus Mesalazine for the Treatment of Ulcerative Colitis: A Randomised Trial." Lancet, vol. 354, no. 9179, 1999, p. 635, https://doi.org/10.1016/s0140-6736(98)06343-0.